Global News

Changes in recruitment

Monday, February 13, 2017

The Pulse on Patient Recruitment by Ashley Tointon

Looking retrospectively, patient recruitment activities have evolved greatly. Unfortunately, some issues are cyclical and see resurgence from time to time. Sending in-person recruitment assistance to sites, leveraging patient advocacy outreach and the increased use of videos are just a few examples of valuable tactics that come in and out of popularity, much like recycled fashion. Is this because we don’t disseminate learning? Is it because we run out of new ideas to solve old issues? Realistically, there are many old patient recruitment problems that have yet to be properly solved. Two major issues yet to be solved are the awareness of clinical trials and how to engage with patients.

[Read More]

GeNeuro, NIH partner to develop novel antibody treatment for ALS

Friday, February 10, 2017

GeNeuro, a biopharmaceutical company developing new treatments for neurological disorders and autoimmune diseases, including multiple sclerosis (MS), has announced the signing of a Cooperative Research and Development Agreement (CRADA) with The National Institute of Neurological Disorders and Stroke (NINDS), part of the NIH, to develop novel therapeutic antibodies for the treatment of amyotrophic lateral sclerosis (ALS). The research will evaluate the ability of these antibodies to neutralise a potential causal factor of ALS, the envelope protein of HERV-K (a family of Human Endogenous Retroviruses, HERVs). 

[Read More]

MedNet Solutions releases iMedNet update

Friday, February 10, 2017

MedNet Solutions, an innovative SaaS-based eClinical technology company that supports the entire spectrum of clinical research, has announced that the latest release of iMedNet, its eClinical solution, is now available for all iMedNet customers. iMedNet is a Software-as-a-Service (SaaS) clinical research technology platform that not only provides Electronic Data Capture (EDC), but also delivers an entire suite of eClinical tools to support the expert management and conduct of clinical trials from start to finish.

[Read More]

Koch Institute receives $1M from Takeda to support immuno-oncology research

Friday, February 10, 2017

Takeda Pharmaceutical and the Koch Institute for Integrative Cancer Research at MIT jointly announced that Takeda will support groundbreaking science in immuno-oncology at the Koch Institute. Over the next two years, the $1 million gift will help to build upon the research currently being conducted by the Institute to investigate the role of the immune response in cancer and develop potential novel treatments.

[Read More]

ERT launched refreshed eCOA technology environment

Friday, February 10, 2017

ERT, a global data and technology company that minimizes risk and uncertainty in clinical trials, has announced the launch of its refreshed eCOA technology environment, which dramatically simplifies the implementation and management of trials that require collection of Clinical Outcomes Assessments.

[Read More]